Biomolecule classification technology developer Arago Bioscience emerged out of Oxford in April this year and has now been backed by two of the university's funds.
Arago Bioscience, a UK-based biomolecule classification technology spinout from University of Oxford, has obtained an undisclosed sum from university venture fund Oxford Science Innovation and co-investment vehicle University of Oxford Innovation Fund (UOIF) IV.
UOIF is managed by Parkwalk Advisors, the fund management arm of commercialisation firm IP Group, to provide spinouts from the university with matching capital from external sources.
Founded in April 2018, Arago Bioscience has devised a biotechnology that detects and quantifies molecules so clients can perform…
